A public enemy has infiltrated the nation's borders. Taken captive in Fulton, N.Y., and identified by a Cornell expert, the adult female alien is the only one of its kind ever discovered in eastern United States.
President David Skorton issued a message of condolence Nov. 15 on the death of Ryan Crowder, who was working in Nicaragua on a sustainable fisheries initiative. A support meeting will be held Nov. 16. (Nov. 15, 2010)
The age at which people become sexually active is genetically influenced – but not when they grow up in stressful, low-income household environments, reports Jane Mendle, assistant professor of human development, in the journal Developmental Psychology.
Several thousand people attended Insectapalooza Oct. 25 to explore the world of creeping, crawling and flying insects. The event not only featured Cornell's insect collection of more than 5 million specimens but also zoo rooms with live specimens.
Cornell has accepted 6,062 applicants for admission to the Class of 2017 this fall, out of 40,006 applications received, the highest number of applications to date and 5.8 percent more than in 2012.
Fourth generation peanut farmer Luke Green of Banks, Ala., produces organically grown peanuts, markets them in his peanut butter -- Luke's Pure Peanuts -- and his small family farm thrives economically when others around him are closing.
Mayor Svante Myrick delivered a keynote address at the the annual Student United Way Leadership Retreat in Alexandria, Va., and Cornell Student United Way co-chairs Christine Roberti and Samuel Coleman attended a briefing with White House officials.
New York, NY (August 20, 2003) -- Surgeons at New York Weill Cornell medical center performed the world's first gene therapy for Parkinson's disease on a 55-year-old New York man on Monday, August 18. The historic surgery, which also marked the first-ever in vivo gene therapy in the brain for an adult neurological disease, was part of a phase I clinical trial approved by the Food and Drug Administration in October 2002. The five-hour procedure was performed by Dr. Michael G. Kaplitt, Director of Stereotactic and Functional Neurosurgery at NewYork-Presbyterian Hospital and Assistant Professor of Neurological Surgery at Weill Cornell Medical College. The patient is recovering normally and is expected to return home today, just two days after the surgery was performed."Monday's surgery represents the realization of nearly 15 years of research in this area," said Dr. Kaplitt. "The goal of our gene therapy approach is to 're-set' a specific group of cells that have become overactive in an affected part of the brain, causing the impaired movements associated with Parkinson's disease. We hope that this trial, which is the first of its kind, will prove to be a safe treatment to allow gene therapy to move forward for Parkinson's disease and other brain disorders."